Firefly Neuroscience, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AIFF research report →
Price Chart
About the company
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders.
- CEO
- Greg Lipschitz
- IPO
- 2002
- Employees
- 17
- HQ
- Kenmore, NY, US
Get TickerSpark's AI analysis on AIFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $11.81M
- P/E
- -1.58
- PEG
- -0.01
- P/S
- 6.13
- P/B
- 1.29
- EV/EBITDA
- -0.58
- Div Yield
- 0.00%
- Gross Margin
- 57.39%
- Op Margin
- -377.84%
- Net Margin
- -386.15%
- ROE
- -71.97%
- ROIC
- -57.90%
Latest fiscal year · YoY change
- Revenue
- $1.14M+957.4%
- Gross Profit
- $645.00K+1473.2%
- Op Income
- $-8,605,000
- Net Income
- $-19,882,000-90.1%
- EPS
- $-1.86-16.3%
- OCF Growth
- -33.1%
- FCF Growth
- -26.7%
- 52W High
- $3.15
- 52W Low
- $0.62
- 50D MA
- $1.12
- 200D MA
- $1.37
- Beta
- 0.57
- RSI (14)
- 35
- Avg Volume
- 2.66M
No earnings-call transcripts are available for AIFF yet.
- Free Float
- 90.8%
- Shares Outstanding
- 15.75M
- Float Shares
- 14.30M
of shares held by institutions
22 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Murchinson Ltd. | 650.00K | 0 |
| Vanguard Group Inc | 503.07K | 0 |
| Blackrock, Inc. | 184.98K | ▼ 2.19K |
| Boothbay Fund Management, LLC | 178.75K | 0 |
| Jane Street Group, LLC | 170.56K | ▲ 102.73K |
| Geode Capital Management, LLC | 121.52K | 0 |
| Vanguard Capital Management LLC | 111.91K | 0 |
| Vanguard Fiduciary Trust Co | 98.61K | ▲ 47.62K |
| State Street Corp | 67.80K | ▲ 21.50K |
| Virtu Financial LLC | 45.36K | ▲ 18.80K |
| Cygnus Capital Advisors, LLC | 44.55K | ▲ 24.51K |
| Citadel Advisors LLC | 38.91K | ▲ 38.91K |
Held by 10 ETFs
Biggest fund positions in AIFF by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 25, 26 | Vnook Stella | other | 84,033 |
| Sep 25, 26 | POSNER BRIAN M | other | 84,033 |
| Sep 25, 26 | Menawat Arun Swarup | other | 126,050 |
| Sep 8, 26 | Paz Jessica Lucia | other | 0 |
| Aug 12, 24 | Lipschitz Gregory | other | 0 |
| Mar 10, 26 | DeCaprio David | other | 44,872 |
| Mar 10, 26 | Lipschitz Gregory | other | 65,988 |
| Oct 28, 25 | Menawat Arun Swarup | other | 73,892 |
| Oct 28, 25 | POSNER BRIAN M | other | 49,262 |
| Oct 28, 25 | Vnook Stella | other | 49,262 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AIFF coverage
Recent articles, reports, and earnings notes.
No research on AIFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AIFF report →Firefly Neuroscience Reports 373% Year-Over-Year Increase in U18 ADHD Evoke™ Scans as Commercial Expansion Accelerates
globenewswire.com · Nov 17
Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform
globenewswire.com · Oct 27
Definitive Healthcare (NASDAQ:DH) versus Firefly Neuroscience (NASDAQ:AIFF) Financial Comparison
defenseworld.net · Oct 4
Firefly Neuroscience and Neurosigma Partner To Expand Non-Drug Pediatric ADHD Care
benzinga.com · Sep 25
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
globenewswire.com · Sep 25
Firefly Neuroscience's Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial's AI-Native Operating System for Brain Medicine
globenewswire.com · Sep 17
Firefly Neuroscience (NASDAQ:AIFF) vs. Pro Medicus (OTCMKTS:PMCUF) Head-To-Head Analysis
defenseworld.net · Aug 12
Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes
globenewswire.com · Aug 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.